Research & Development: Page 37
-
PharmaVoice Team/PharmaVoice
SHOWCASE: Rare Disease: Rare But Not Scarce: The Struggle Faced By Millions
A single rare disease may afflict just a small number of people, but collectively up to 400 million people globally live with a rare disease. Exactly what is a rare disease? Collectively, rare isn’t scarce or infrequent. That’s the message that the organizers of Rare Disease Day 2020 are striving...
By PharmaVoice Team • Feb. 1, 2020 -
PharmaVoice Team/PharmaVoice
Lessons Learned from rare Disease First Commercial Launches
There’s nothing more exciting, and more nerve-wracking, than a new product launch — even more so when it’s a company’s first commercial launch. We’ve had the privilege of working on more than 10 first commercial launches, most of them in rare disease. As an agency partner we’ve worked with biotec...
By Annemarie Armstrong • Feb. 1, 2020 -
Explore the Trendline➔
Stock via Getty Images
TrendlineOncology R&D
Cancer research remains a prime focus for the industry and often leads to pharma’s most impactful breakthroughs.
By PharmaVoice staff -
PharmaVoice Team/PharmaVoice
How the "Power of Why" Can Improve Adherence Rates in Rare Disease
Best-selling author and motivational speaker, Simon Sinek, is best known for his 2009 Ted Talk challenging organizations to set aside their list of product benefits and features to focus on the core purpose of their existence. He asks, WHY are you motivated to do what you do every day? Sinek sug...
By Kathi Hensen • Feb. 1, 2020 -
PharmaVoice Team/PharmaVoice
Finding Patients With Rare Diseases — Two Truths and a Lie
The hope for many companies developing drugs for rare diseases is this: the significant unmet need, given a dearth of treatment options, will drive demand and thus product uptake. Unfortunately, the reality is more challenging. While we have seen a significant increase in the number of drugs for ...
By Susan Abedi • Feb. 1, 2020 -
PharmaVoice Team/PharmaVoice
R&D INFLUENCER: Bert Hartog, Ph.D. — Janssen Pharmaceutical Companies of Johnson & Johnson
Unlocking clinical Bottlenecks We need to make more trials more accessible to more people. participate Bert Hartog, Ph.D., senior director at Janssen Clinical Innovation, Janssen Research & Development LLC is driven to eliminate the challenges preventing patients from participating in clinica...
By Bert Hartog • Feb. 1, 2020 -
PharmaVoice Team/PharmaVoice
R&D INFLUENCER: Jill Johnston — WCG, Clinical Services Organization
Breaking Down the Roadblocks to Site Activation My focus is on getting life-saving drugs to patients as quickly as possible by reducing the time it takes sites to enroll patients into trials. There’s a big difference between people with a vision and those who can execute on that idea. Jill Johnst...
By Jill Johnston • Feb. 1, 2020 -
PharmaVoice Team/PharmaVoice
Commanders & Chiefs: Innovators
Chief innovators provide their insights on what innovation means to them, keys to driving innovation, and what it takes to foster an innovation-driven company culture. Defining Innovation Garde. We define innovation as breaking business barriers through measurable and unique client-focused soluti...
By PharmaVoice Team • Feb. 1, 2020 -
PharmaVoice Team/PharmaVoice
Letter from the Editor
The Road Ahead As we head into 2020, closing out a decade punctuated by an ever-changing healthcare dynamic shaped by scientific discoveries, technological breakthroughs, innovation at every level, as well as global geopolitical forces, there is no doubt that the status quo is no longer a busines...
By Taren Grom • Jan. 1, 2020 -
PharmaVoice Team/PharmaVoice
Innovator's Corner
Fish Skin for Wounds Fertram Sigurjonsson, Founder and CEO of Kerecis, talks about his company’s skin-substitution technology, which comes from Icelandic cod. Fertram Sigurjonsson started Kerecis because he wanted to help people avoid life-altering amputations, which often result from hard-to-hea...
By Fertram Sigurjonsson • Jan. 1, 2020 -
PharmaVoice Team/PharmaVoice
Last Word
Creating an Innovative Culture Fabrice Chouraqui, former president of Novartis Pharmaceuticals US, discusses his vision for creating an organization that is fueled by innovation. PV: How do you define innovation and what was your vision for reshaping of the pharmaceutical division of Novartis in ...
By Fabrice Chouraqui • Jan. 1, 2020 -
PharmaVoice Team/PharmaVoice
Small Pharma Driving Big Pharma Innovation
The Path to R&D Innovation Lies in the Power of Small Pharma Visionary thought leaders such as Bernard Munos of InnoThink and the Milken Institute and Paul Stoffels, M.D., vice chairman of the executive committee and chief scientific officer, Johnson & Johnson, have been advocating for ye...
By Robin Robinson • Jan. 1, 2020 -
PharmaVoice Team/PharmaVoice
What Do Patients Want From Virtual Trials?
How to plan for a successful patient-centric virtual trial Virtual and hybrid clinical trials, which require few or no visits to a trial site, have arrived as part of the new frontier of innovative, patient-centric research models. Through telemedicine, online patient portals, and connected devic...
By Josh Rose • Jan. 1, 2020 -
PharmaVoice Team/PharmaVoice
Letter from the Editor
Imagining what’s next… By 2020, it’s estimated that 1.7 megabytes of data will be created every second for every person on earth; 90% of the world’s data has been created in the last two years; healthcare data is doubling every 18 months; 5 billion people around the world lack access to surgeons;...
By Taren Grom • Nov. 19, 2019 -
PharmaVoice Team/PharmaVoice
Artificial Intelligence
Novartis and Microsoft Collaborate on AI Lab Trend Watch: AI Partnerships and New Therapeutic Candidates Novartis has founded the Novartis AI innovation lab and is collaborating with Microsoft on the effort. The new lab aims to bolster Novartis AI capabilities from research through commercializat...
By PharmaVoice Team • Nov. 19, 2019 -
PharmaVoice Team/PharmaVoice
Last Word
Remaking Clinical Trials with the Patient in Mind Tammy Guld, Global Team Lead for Janssen Clinical Innovation, talks about how the clinical trial experience for patients can be improved. PV: How can pharma companies improve the clinical trial experience for patients and get medicines to market f...
By Tammy Guld • Nov. 19, 2019 -
PharmaVoice Team/PharmaVoice
The Year Ahead…
We ask more than 130 experts, what needs to happen to address inefficiency and productivity to achieve aspirational goals for healthcare in the future. For this year’s special 2020 Year in Preview issue, we posed 20 provocative questions to our community of thought leaders, who represent all aspe...
By Taren Grom • Nov. 19, 2019 -
PharmaVoice Team/PharmaVoice
Dr. Robot
Robots and docs — automation and clinician. In Disney’s animated hit Big Hero 6, we got a glimpse of what a future of a robot-enabled healthcare future might look like. Disney’s Baymax is an inflatable robot whose sole purpose is to take care of people in everyday life. But real-life medical robo...
By Taren Grom • Nov. 19, 2019 -
PharmaVoice Team/PharmaVoice
Bringing Humanity Back to Healthcare
Technology can seem impersonal, but it can also be the driver for enabling more personal connections with patients. From the development of medicines by pharma companies to advancements in treatment protocols to using data to better apply therapeutic regimens, the healthcare industry is committed...
By Kim Ribbink • Nov. 19, 2019 -
PharmaVoice Team/PharmaVoice
Creating a Culture of Innovation
To create a culture of innovation, pharma companies will need to encourage different ways of thinking. By definition, innovation is “a new idea, creative thoughts, new imaginations in form of device or method." Innovation is also viewed as the application of better solutions that meet new require...
By Taren Grom • Nov. 19, 2019 -
PharmaVoice Team/PharmaVoice
Innovator's Corner
Detecting cancer early is the key to defeating it. Laboratory for Advanced Medicine (LAM) is working to detect cancer in its infancy when treatment options have the best chance to be successful. The company’s platform technology, IvyGene, detects the presence of cancer in blood samples and gives ...
By PharmaVoice Team • Oct. 1, 2019 -
PharmaVoice Team/PharmaVoice
HealthTech
First Patient Begins CVS Trial With Home Dialysis Machine Trend Watch: Telehealth Developments: At-home dialysis; skin patches for melanoma treatment; sweat monitoring, and norovirus detection. In August, the first patient involved in a clinical trial for a new CVS-funded home hemodialysis machin...
By PharmaVoice Team • Oct. 1, 2019 -
PharmaVoice Team/PharmaVoice
Artificial Intelligence
MIT Model Predicts Cognitive Decline Due to Alzheimer’s Trend Watch: From Precision Medicine to Precision Diagnosis, AI Provides More Exact Approach A new model developed at MIT can help predict if patients at risk for Alzheimer’s disease will experience clinically significant cognitive decline d...
By PharmaVoice Team • Oct. 1, 2019 -
PharmaVoice Team/PharmaVoice
Last Word
Transitioning Emerging Companies into Commercial Powerhouses Ronald Andrews, President and CEO of OncoCyte and a serial entrepreneur with nearly 30 years of experience, shares lessons for fostering the growth of development-stage companies. PV: You joined OncoCyte as president and CEO in July 201...
By Ronald Andrews • Oct. 1, 2019 -
PharmaVoice Team/PharmaVoice
Pharma's Future in Virtual Healthcare
With virtual health transforming the entire healthcare landscape, pharma is leveraging digital health tools to improve its processes. As healthcare is swept up in the extensive development of health management apps, telemedicine platforms, AI diagnosis, and the use of video, mobile apps, text mes...
By Robin Robinson • Oct. 1, 2019 -
PharmaVoice Team/PharmaVoice
SHOWCASE: Artificial Intelligence: Artificial Intelligence Gains Ground Across Healthcare
Adoption of artificial intelligence is accelerating across the healthcare industry. According to a survey of 50 executives at healthcare companies currently using AI, half believe AI will be broadly adopted across the industry by 2025. However, nearly half of U.S. companies say there is a need fo...
By PharmaVoice Team • Oct. 1, 2019
Previous
